OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine.
Lipton RB, Varon SF, Grosberg B, McAllister PJ, Freitag F, Aurora SK, Dodick DW, Silberstein SD, Diener HC, DeGryse RE, Nolan ME, Turkel CC.
Lipton RB, et al. Among authors: grosberg b.
Neurology. 2011 Oct 11;77(15):1465-72. doi: 10.1212/WNL.0b013e318232ab65. Epub 2011 Sep 28.
Neurology. 2011.
PMID: 21956721
Clinical Trial.